ABEONA THERAPEUTICS ($ABEO) posted quarterly earnings results for Q4 2025 on Tuesday, March 17th. The company reported earnings of -$0.34 per share, beating estimates of -$0.36 by $0.02. The company also reported revenue of $5,420,000, beating estimates of $5,375,573 by $44,427.
You can see Quiver Quantitative's $ABEO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ABEONA THERAPEUTICS Insider Trading Activity
ABEONA THERAPEUTICS insiders have traded $ABEO stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ABEO stock by insiders over the last 6 months:
- VISHWAS SESHADRI (Chief Executive Officer) has made 0 purchases and 5 sales selling 139,355 shares for an estimated $741,257.
- JOSEPH WALTER VAZZANO (Chief Financial Officer) has made 0 purchases and 3 sales selling 28,486 shares for an estimated $151,973.
- MARK ALVINO has made 0 purchases and 2 sales selling 28,500 shares for an estimated $141,741.
- BRENDAN M. O'MALLEY (SVP, Chief Legal Officer) has made 0 purchases and 3 sales selling 23,632 shares for an estimated $126,634.
- CHRISTINE BERNI SILVERSTEIN sold 20,070 shares for an estimated $102,168
- ERIC CROMBEZ sold 16,284 shares for an estimated $82,895
- DONALD A. WUCHTERL sold 14,814 shares for an estimated $75,412
- MADHAV VASANTHAVADA (Chief Commercial Officer) sold 12,610 shares for an estimated $66,657
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ABEONA THERAPEUTICS Hedge Fund Activity
We have seen 57 institutional investors add shares of ABEONA THERAPEUTICS stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC added 2,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,540,000
- WESTERN STANDARD LLC removed 1,249,957 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,587,273
- TANG CAPITAL MANAGEMENT LLC added 1,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,270,000
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 701,288 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,695,787
- ABERDEEN GROUP PLC added 616,413 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,248,496
- BALYASNY ASSET MANAGEMENT L.P. added 591,737 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,118,453
- DIAMETRIC CAPITAL, LP added 521,220 shares (+300.9%) to their portfolio in Q4 2025, for an estimated $2,746,829
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ABEONA THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $ABEO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for ABEONA THERAPEUTICS, check out Quiver Quantitative's $ABEO forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
